Beta‐blockers showed no clear difference in total coronary heart disease compared with calcium‐channel blockers (moderate certainty).
Beta‐blockers showed no clear difference in withdrawal due to adverse effect compared with calcium‐channel blockers (low certainty).
Beta‐blockers showed no clear difference in total mortality compared with renin‐angiotensin system inhibitors (moderate certainty).
Beta‐blockers showed no clear difference in total cardiovascular disease compared with renin‐angiotensin system inhibitors (low certainty).
Beta‐blockers probably leads to higher total stroke compared with renin‐angiotensin system inhibitors (moderate certainty).
Beta‐blockers showed no clear difference in total coronary heart disease compared with renin‐angiotensin system inhibitors (low certainty).
Beta‐blockers may leads to lower total cardiovascular disease compared with placebo (low certainty).
Beta‐blockers probably leads to higher withdrawal due to adverse effect compared with renin‐angiotensin system inhibitors (moderate certainty).
Beta‐blockers may leads to lower total stroke compared with placebo (low certainty).
Beta‐blockers showed no clear difference in total coronary heart disease compared with placebo (moderate certainty).
Beta‐blockers showed no clear difference in withdrawal due to adverse effect compared with placebo (low certainty).
Beta‐blockers showed no clear difference in total mortality compared with diuretics (moderate certainty).
Beta‐blockers showed no clear difference in total cardiovascular disease compared with diuretics (moderate certainty).
Beta‐blockers showed no clear difference in total stroke compared with diuretics (low certainty).
Beta‐blockers showed no clear difference in total coronary heart disease compared with diuretics (low certainty).
The review found no eligible studies for this question.
Beta‐blockers showed no clear difference in all‐cause mortality compared with placebo, no treatment or surveillance only (low certainty).
Beta‐blockers showed no clear difference in clinically important non‐fatal end point as defined byShores… compared with placebo, no treatment or surveillance only (low certainty).
Beta‐blockers showed no clear difference in acute aortic dissection compared with placebo, no treatment or surveillance only (low certainty).
Beta‐blockers showed no clear difference in aortic regurgitation compared with placebo, no treatment or surveillance only (low certainty).